|
| Non-Axillary N (%) | Axillary N (%) | p-Value |
| Age |
|
| <0.001 |
| <50 yo | 155 (49.4) | 379 (28.6) |
|
| >50 yo | 159 (50.6) | 945 (71.4) |
|
| Injection Method |
|
| 0.009 |
| Intratumoral | 204 (65.2) | 781 (58.5) |
|
| Peritumoral | 24 (7.7) | 82 (6.1) |
|
| Subdermal | 84 (26.8) | 436 (31.6) |
|
| Subareolar | 1 (0.3) | 35 (2.6) |
|
| Treatment |
|
| 0.014 |
| Tumorectomy | 261 (82.1) | 1162 (87.5) |
|
| Mastectomy | 57 (17.9) | 166 (12.5) |
|
| Tumor Location |
|
| <0.001 |
| Outer Quadrants | 122 (39.2) | 685 (53.2) |
|
| Inner Quadrants | 189 (60.8) | 603 (46.8) |
|
| Vascular/Lymphatic Infiltration |
|
|
|
| Yes | 54 (33.5) | 375 (26.3) | 0.064 |
| No | 107 (66.5) | 522 (73.7) |
|
| Number of Nodes |
|
|
|
| 1 or more | 101 (31.8) | 328 (24.4) | 0.007 |
| 0 | 217 (68.2) | 1014 (75.6) |
|
| Free Margins |
|
| 0.501 |
| Cytology |
|
| 0.169 |
| Micrometastasis |
|
| 0.843 |
| Single/Multiple |
|
| 0.346 |
| Histology |
|
| 0.130 |
| Hormone Receptors |
|
| 0.222 |
| Erb2 |
|
| 0.184 |